FDA denies approval of TAK-721 (budesonide oral suspension) for EoE Takeda, the pharmaceutical company developing TAK-721 (budesonide oral sus ...

For Immediate Release ...

The American Partnership for Eosinophilic Disorders (APFED) is closely monitoring developments regarding the novel coronavirus (COVID-19) outbreak and the poten ...

This week, APFED was onsite at the American College of Gastroenterology’s 84th Annual Scientific Meeting and Postgraduate Course (ACG 2019) where attendees fr ...